> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-234/
- Published: 2019-08-18T12:00:00.000Z
- Updated: 2026-09-15T01:44:28.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5144798

[**Panel to Discuss GSK NDA for OTC Nicotine Spray**](https://www.fdaweb.com/panel-to-discuss-gsk-nda-for-otc-nicotine-spray/)  
*Federal Register* notice: FDA announces a 9/18 panel meeting on a GlaxoSmithKline NDA for the over-the-counter marketing of nicotine oral spray for withdrawal symptoms. 08/16/2019 

[**Nonclinical Osteoporosis Drug Study Guide**](https://www.fdaweb.com/nonclinical-osteoporosis-drug-study-guide/)  
*Federal Register*: FDA makes available a final guidance on osteoporosis drug nonclinical studies. 08/16/2019 

[**Info Collection Extension for ‘Dear Doctor’ Letters**](https://www.fdaweb.com/info-collection-extension-for-dear-doctor-letters-2/)  
*Federal Register* notice: FDA seeks comments on an information collection extension for the guidance on “dear doctor” letters. 08/16/2019

[**Info Collection on Device Sterilization Agreements**](https://www.fdaweb.com/info-collection-on-device-sterilization-agreements-2/)  
*Federal Register* notice: FDA sends to OMB an information collection extension entitled “Agreement for Shipment of Devices for Sterilization — 21 CFR 801.150.” 08/15/2019

[**Info Collections Consolidated for Informed Consent/IRBs** ](https://www.fdaweb.com/info-collections-consolidated-for-informed-consent-irbs/)*Federal Register* notice: FDA seeks comments on an information collection revision for “Protection of Human Subjects; Informed Consent; and Institutional Review Boards (IRB) — 21 CFR Parts 50 and 56.” 08/14/2019

[**Draft Guide on Gastroparesis Drug Development**](https://www.fdaweb.com/draft-guide-on-gastroparesis-drug-development/)  
*Federal Register* notice: FDA posts a draft guidance on gastroparesis drug development. 08/14/2019

[**Guide on Drug Labeling About Child Packaging**](https://www.fdaweb.com/guide-on-drug-labeling-about-child-packaging/)  
*Federal Register* notice: FDA makes available a final guidance entitled “Child-Resistant Packaging Statements in Drug Product Labeling.” 08/14/2019

[**Mammography Quality Assurance Advisory Panel Renewal**](https://www.fdaweb.com/mammography-quality-assurance-advisory-panel-renewal/)  
*Federal Register* notice: FDA renews the National Mammography Quality Assurance Advisory Committee for an additional two years. 08/13/2019